NCT06972654View on ClinicalTrials.gov

Analgesic Effects of Combined Nalbuphine-bupivacaine Versus Dexamethasone-bupivacaine in Pericapsular Nerve Group Block (PENG) After Hip Surgeries: A Randomized Clinical Study

NARecruitingINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

December 1, 2025

Study Completion Date

January 1, 2026

Conditions
Analgesia, Postoperative
Interventions
PROCEDURE

Group Nalupnine

Patients will receive a unilateral ultrasound-guided pericapsular nerve group (PENG) block with a combination of 20 mL of bupivacaine 0.25%- and 2 ml nalbuphine (20 mg), with total volume 22ml.

PROCEDURE

Group Dexamethasone

Patients will receive a unilateral ultrasound-guided PENG block with a combination of 20 mL of bupivacaine 0.25%- and 2 ml dexamethasone (8 mg), with total volume 22ml.

Trial Locations (1)

Unknown

RECRUITING

Faculity of medicine, Zagazig university, Zagazig, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV